By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel's discussion on RCAT highlights the company's potential in the defense drone sector, with a growing backlog and government contract wins. However, the lack of profitability, high cash burn rate, and competition from better-capitalized firms pose significant risks to the company's future.
Risk: High cash burn rate and limited runway, which could invert the backlog growth if new contracts don't materialize soon.
Opportunity: Growing backlog and government contract wins, which could lead to a breakout contract win and improved financials.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Red Cat Holdings, Inc. (NASDAQ:RCAT) was among the stocks Jim Cramer looked at as he discussed the recent bounce in software stocks. When a caller inquired about the stock during the lightning round, Cramer commented:
Okay, you know, look, we don’t mind the drones. I know that Ben Stoto has been following this Red Cat closely. My problem is they’re not making a lot of money. I think there are others that are better. I think it’s a good spec. How about that? It’s a good spec.
Photo by jason briscoe on Unsplash
Red Cat Holdings, Inc. (NASDAQ:RCAT) develops drone systems and control technologies for military, government, and commercial use. A caller inquired about the stock during the October 15, 2025, episode. The Mad Money host replied:
Okay, so this is a Ben Stoto favorite, not really. It’s a drone company. We are on the fence about buying drone companies that aren’t making money.
It is worth noting that since the above comment was aired, the company’s stock is down by 12%.
While we acknowledge the potential of RCAT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"RCAT’s current valuation ignores the massive tailwinds from the Pentagon’s shift toward low-cost, mass-producible drone fleets."
Cramer’s dismissal of RCAT based on profitability misses the point of the current defense-tech cycle. We are seeing a massive shift toward 'attritable' drone warfare, where the Pentagon’s Replicator initiative prioritizes volume and rapid iteration over legacy, high-cost platforms. RCAT’s Teal 2 drone is gaining traction in government contracts, which provides a revenue floor. While the lack of GAAP profitability is a valid concern, the valuation is currently pricing in a 'speculative' failure rather than the potential for a breakout contract win. Investors should focus on backlog growth and government funding cycles rather than current bottom-line losses, which are typical for high-growth firms scaling in a nascent, mission-critical sector.
The defense sector is notoriously difficult for small-cap entrants to scale due to long procurement cycles and the overwhelming lobbying power of incumbents like Lockheed Martin or AeroVironment.
"RCAT's lack of profitability makes it vulnerable to further downside in a market prioritizing earnings over speculative drone hype."
Jim Cramer's tepid endorsement of RCAT as a 'good spec' but not a buy due to absent profitability perfectly captures the stock's Achilles' heel: drone development burns cash without near-term margins, especially versus cash-flowing software peers amid the recent bounce. The 12% post-comment drop shows traders agreeing, punishing unprofitable specs in a high-rate world. Missing context: RCAT's military/government drone niche benefits from surging defense budgets (e.g., Ukraine, Taiwan tensions), but execution on contracts is unproven. Article's AI stock promo reeks of distraction from RCAT's volatile path.
Cramer's contrarian track record suggests his dismissals often signal buy opportunities, and if RCAT lands DoD contracts, profitability could accelerate faster than skeptics expect.
"A TV host's throwaway comment on profitability is insufficient to assess a defense contractor whose revenue recognition and margins may be structurally opaque to retail investors."
This is a non-event dressed as news. Cramer's comment—'good spec' but unprofitable—is neither a sell signal nor an endorsement; it's fence-sitting. The 12% post-comment decline is presented as causation but lacks evidence of correlation timing or volume. More importantly: RCAT operates in defense/government contracting, a sector with multi-year procurement cycles and classified revenue streams that don't show up in public financials. Cramer's 'not making money' critique may miss deferred revenue recognition or milestone-based contracts typical in defense. The article's pivot to 'AI stocks are better' is editorial bias, not analysis. We need RCAT's actual cash position, backlog, and contract wins—not a TV soundbite.
If RCAT genuinely has weak unit economics and Cramer's skepticism reflects broader institutional hesitation, the 12% drop could be the start of a longer repricing, especially if defense budget allocations shift away from drone systems.
"Without a clear path to profitability or cash-flow resilience, RCAT remains a high-risk speculative bet rather than a validated turnaround."
The headline frames RCAT as a speculative pick and echoes Cramer's profit-not-needed narrative, but the piece omits critical risk factors that could derail a rebound. RCAT’s profitability questions imply cash burn and potential dilution, which are non-trivial for a small-cap with limited visibility. The drone/defense space carries regulatory headwinds, export controls, and competition that can compress margins or stall deals. The article also glosses over whether RCAT has durable government contracts or meaningful backlog to justify optimism. Optionality exists if RCAT lands a material contract or OEM arrangement, but absent clear cash-flow catalysts, the stock remains highly uncertain and data-dependent.
Counterpoint: a large DoD contract or major OEM win could dramatically alter RCAT's revenue visibility and margins, creating upside even if current metrics look weak. But the odds and timing are highly uncertain.
"RCAT's lack of scale makes them structurally disadvantaged against better-funded defense-tech incumbents in the race for DoD procurement dominance."
Gemini’s focus on 'attritable' warfare ignores the supply chain reality: RCAT is competing for DoD dollars against firms like Shield AI and Anduril, which are far better capitalized. Claude is right that defense contracts are opaque, but that opacity is a feature for incumbents, not a bug for a micro-cap. RCAT isn't just fighting for market share; they are fighting for survivability against entities that have already solved the 'production at scale' hurdle that RCAT is still burning cash to reach.
"RCAT's small-UAS niche complements bigger players in DoD's multi-vendor Replicator push, bolstering near-term backlog over existential threats."
Gemini, your pivot to 'survivability' vs. Anduril/Shield overstates direct rivalry—RCAT's Teal 2 (Group 2 UAS, <20lbs) targets swarming attritables complementary to their autonomous stacks, per Replicator specs. Unflagged: RCAT's Q1 backlog at $7.8M (up 50% YoY), with US Army/Marine wins providing $5M+ floor. Dilution risk real, but M&A bait if execution holds.
"Backlog growth is meaningless if cash runway doesn't cover the lag between contract award and cash collection in defense."
Grok's $7.8M backlog figure needs scrutiny—that's quarterly run-rate, not contract value. More critically: nobody's addressed RCAT's cash burn rate or runway. If they're burning $2-3M/quarter to defend a $7.8M backlog, the math inverts fast. Anduril/Shield's capitalization advantage isn't just about scale; it's about surviving the 18-24 month gap between contract award and meaningful revenue recognition. RCAT could be acquisition bait, but bait gets acquired cheap.
"Backlog and a floor are not reliable near-term revenue drivers for RCAT; without immediate, material contract wins or low burn, the stock remains at risk."
Responding to Grok: The $7.8M Q1 backlog and $5M+ floor look supportive, but backlog isn't revenue—awards slip, are delayed, or canceled. The key risk is execution: DoD contracts in defense microcapships often stall and conversion to actual cash can lag years. Without visibility into burn rate and runway, the floor may prove illusory if new contracts don't materialize soon. That caveat applies even if DoD funding remains robust.
The panel's discussion on RCAT highlights the company's potential in the defense drone sector, with a growing backlog and government contract wins. However, the lack of profitability, high cash burn rate, and competition from better-capitalized firms pose significant risks to the company's future.
Growing backlog and government contract wins, which could lead to a breakout contract win and improved financials.
High cash burn rate and limited runway, which could invert the backlog growth if new contracts don't materialize soon.